Pulmonary hypertension in left-to-right shunt lesions, such as ventricular septal defect (VSD), patent ductus arteriosus, atrial septal defect (ASD) and atrioventricular canal defect is termed hyperkinetic pulmonary hypertension. Hyperkinetic pulmonary hypertension is usually reversible if the cause is treated before development of permanent changes in pulmonary arterioles. A unidirectional flap valve (UVP) VSD patch closure is a good alternative in children with large VSD with Eisenmenger physiology. The technique of unidirectional valved patch VSD closure obviates the need for extracorporeal membrane oxygenation and nitric oxide ventilation in patients who are at risk of pulmonary hypertensive crises postoperatively.
blood flow, a direct transmission of the systemic pressure to the pulmonary artery, and an increase in pulmonary vascular resistance (PVR) by compensatory pulmonary vasoconstriction. 2 The pulmonary vasoconstriction is a defence mechanism for preventing the development of congestive heart failure. Hyperkinetic pulmonary hypertension is usually reversible if the cause is treated before development of permanent changes in pulmonary arterioles. If the large left-to-right shunt lesions are left untreated, irreversible changes take place in the pulmonary vascular bed, leading to severe pulmonary hypertension and cyanosis subsequent to reversal of the left-to-right shunt. This stage is called Eisenmenger's syndrome or pulmonary vascular obstructive disease (PVOD). 3 
JOPE
A unidirectional valved patch (UVP) VSD closure with polytetrafluoroethylene was performed on cardiopulmonary bypass (CPB) using standard institutional protocol. Phenoxybenzamine 0.5 mg/kg i.v. was administered slowly after aortic cannulation so as to decrease PVR and facilitate weaning from CPB. The patch had the same width as the size of the defect but approximately one and half times the length of the defect. A 4 mm fenestration was made into it. The patch was then folded upon itself to achieve adequate dimensions for closure of the VSD covering the fenestration in a valved mechanism ( Figs 3A and B) . Thereafter, the patch was sutured to the edges of VSD in a way that the flap lay toward the left ventricular side and opened downward toward the left ventricular apex in order to prevent left ventricular outflow tract (LVOT) obstruction during systole. The PFO was closed. The CPB time was 60 minutes and aortic cross clamp time was 40 minutes. There was return of spontaneous sinus rhythm on aortic cross clamp removal. Patient was weaned from CPB with inotropic support of 5 µg/kg/min dobutamine and 0.5 µg/kg/min nitroglycerin. Transesophageal echocardiography examination demonstrated the UVP patch with blood flow from right ventricle to left ventricle during systole for a brief period shown that results after closure of a large VSD with Eisenmenger physiology are dependent upon the severity of pulmonary hypertension at the time of closure.
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Patients with VSD and pulmonary hypertension undergoing VSD closure have high mortality and morbidity.
In addition, the inflammatory response after CPB leads to release of thromboxane A2 and catecholamines. These vasoactive substance aggravate pulmonary hypertension. Protamine reaction can also make pulmonary hypertension crisis worse. 6 Usually, surgeons leave an interatrial communication to decompress the right atrium and right ventricle during pulmonary hypertensive crisis. However, shunting across this communication is often unreliable with the potential for a left-to-right shunt when the pulmonary arterial pressures decrease. 7 Another approach is a fenestrated VSD patch that converts a large VSD into a small VSD. The fenestration allows for a right-to-left shunt in the case of pulmonary hypertensive crisis. With sustained pulmonary hypertension, the fenestration would allow for a right-to-left shunt with the inherent risk of systemic embolization. But once the PAP decreases, it has the potential for left-to-right shunt along with associated complication of infective endocarditis.
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A UVP VSD patch closure is a good alternative in children with pulmonary hypertension and elevated PVR. 9 It prevents death from acute right ventricular failure and refractory pulmonary hypertension. 10 For a short period after weaning from CPB, the PAP may be (supra) systemic in patients with severe pulmonary hypertension preoperatively. The UVP at VSD position will shunt from right ventricle to left ventricle for such duration. When the PAP reduces below systemic pressure, the UVP closes to abolish the shunt akin to the PFO. Using color flow and continuous wave Doppler, the direction and magnitude of the shunt can be identified. The systolic PAP in this situation can be estimated as: Systolic PAP = systolic blood pressure + ∆ (RV-LV) Where, ∆ (RV-LV) is the gradient across the VSD. Another important consideration is to rule out LVOT obstruction even though the flap is so placed that it opens downward toward the left ventricular during systole and does not impede blood flow.
The technique of UVP VSD closure may allow management of patients with VSD and Eisenmenger physiology at risk of pulmonary hypertensive crises postoperatively in the absence of facilities of extracorporeal membrane oxygenation and nitric oxide ventilation.
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